Sep 16, 2021PDE6BCoave Therapeutics and Théa Open Innovation sign exclusive agreement Coave Therapeutics enters into an exclusive licensing, co-development, and commercialization agreement with Théa Pharma.
Aug 12, 2020PDE6BFDA grants fourth ODD for treatment of PDE6B gene mutation-associated retinal diseasesFDA granted 4th Orphan Drug Designation for novel gene therapy product candidate (OCU400, Ocugen Inc.) in treatment of PDE6B gene mutation.
Apr 18, 2018PDE6BLongitudinal Clinical Follow-up and Genetic Spectrum of Patients with Rod-Cone Dystrophy associatedCompares genotype, phenotype, and structural changes in patients with rod-cone dystrophy (RCD) associated with mutations in PDE6A or PDE6B
Oct 15, 2016PDE6BPrenylated retinal ciliopathy protein RPGR interacts with PDE6B, Regulates ciliary localization of Joubert syndrome-associated protein INPP5E Kollu N. Rao, Wei Zhang, Linjing Li, Manisha Anand, and...